JuneYao Health Drinks, The First Lactic Acid Bacteria Stock

On the evening of April 25, JuneYao Health released a report for the first quarter of 2022, showing that the company’s net profit declined by 71.6%. Since its listing in August 2020, the company has experienced two consecutive years of net profit declines, and the lactic acid bacteria product “Werdery” has also become a performance drag. Such a performance reveals that JuneYao Health’s products are not competitive and lack differentiated competitive advantages. Since 2020, JuneYao Health has not only acquired beverage companies to enter the mineral water category, but also started to cultivate probiotic products and hyaluronic acid categories in order to find new growth opportunities. (Source: sohu.com)

Visit HPA-China’s Information Hub, CLICK HERE